TVTX — Travere Therapeutics Inc
In 2026 Q2, 6 of the 140 tracked hedge funds reported a position in Travere Therapeutics Inc (TVTX), worth $263.48M combined. Over the quarter 3 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $104.14M | 0.14% | -6.8% |
| Emerald | $90.95M | 2.10% | +2.8% |
| Emerald Mutual | $58.63M | 2.10% | +9.2% |
| Essex | $7.60M | 1.00% | -17.2% |
| Kohlberg | $1.18M | 0.01% | NEW |
| Quadrature | $983.50K | 0.00% | -45.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.